National Health Investors, Inc. (NYSE:NHI) Receives Average Recommendation of “Moderate Buy” from Analysts

National Health Investors, Inc. (NYSE:NHI) has been assigned an average recommendation of “Moderate Buy” from the six research firms that are presently covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $76.33.

Several research firms recently issued reports on NHI. StockNews.com cut National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, October 15th. Wells Fargo & Company cut shares of National Health Investors from an “overweight” rating to an “equal weight” rating and lifted their target price for the stock from $81.00 to $86.00 in a research note on Tuesday, October 1st. Truist Financial upped their target price on shares of National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a report on Friday, August 30th. Finally, Bank of America initiated coverage on shares of National Health Investors in a research note on Tuesday, September 24th. They issued a “buy” rating and a $92.00 price target on the stock.

National Health Investors Stock Performance

Shares of NHI stock opened at $72.33 on Friday. The business has a fifty day moving average of $77.18 and a 200 day moving average of $75.32. National Health Investors has a 1 year low of $51.59 and a 1 year high of $86.13. The company has a debt-to-equity ratio of 0.92, a current ratio of 10.29 and a quick ratio of 10.29. The firm has a market capitalization of $3.29 billion, a price-to-earnings ratio of 24.85, a price-to-earnings-growth ratio of 5.05 and a beta of 1.04.

National Health Investors (NYSE:NHI) last issued its earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 EPS for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.42). The company had revenue of $63.32 million during the quarter, compared to analysts’ expectations of $67.93 million. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The firm’s quarterly revenue was up 1.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.08 EPS. As a group, research analysts expect that National Health Investors will post 4.42 earnings per share for the current year.

National Health Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 29th. Stockholders of record on Tuesday, December 31st will be paid a $0.90 dividend. This represents a $3.60 annualized dividend and a dividend yield of 4.98%. The ex-dividend date of this dividend is Tuesday, December 31st. National Health Investors’s payout ratio is 123.71%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. Strategic Financial Concepts LLC acquired a new stake in shares of National Health Investors in the 2nd quarter valued at $28,000. Thrivent Financial for Lutherans purchased a new stake in National Health Investors during the 3rd quarter worth about $2,426,000. Acadian Asset Management LLC acquired a new position in shares of National Health Investors during the 2nd quarter worth about $457,000. LSV Asset Management increased its holdings in shares of National Health Investors by 3.7% in the 2nd quarter. LSV Asset Management now owns 131,400 shares of the real estate investment trust’s stock valued at $8,900,000 after acquiring an additional 4,700 shares during the last quarter. Finally, ClariVest Asset Management LLC acquired a new stake in shares of National Health Investors during the 2nd quarter worth about $2,465,000. 62.51% of the stock is owned by institutional investors and hedge funds.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.